ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2026
Trends and recipient outcomes in multiorgan transplantation in the United States 2013-2023.
Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Multiorgan transplantation (MOT) in the United States is increasing, but data on the epidemiology and posttransplant outcomes are lacking. Using the Scientific Registry of Transplant Recipients database, we examined annual transplant volume, mortality, and graft failure in adult recipients who received a liver, heart, lung, and/or kidney transplant between 2013 and 2023. A total of 380 938 transplant recipients were included in the present study. MOT volume for the liver, heart, lung, and kidney increased between 2013 and 2023. Relative to liver transplantation alone, liver-kidney (adjusted hazard ratio [aHR], 1.22; 95% confidence interval [CI], 1.16-1.29), liver-heart (aHR, 1.82; 95% CI, 1.38-2.40), and liver-lung transplantation (aHR, 2.63; 95% CI, 2.01-3.44) were associated with increased mortality. Relative to heart transplantation alone, heart-liver (aHR, 1.49; 95% CI, 1.17-1.90) and heart-lung (aHR, 2.52; 95% CI, 2.15-2.96) were associated with increased mortality. Relative to lung transplantation alone, lung-heart transplantation (aHR, 1.25; 95% CI, 1.05-1.49) was associated with increased mortality. Compared with kidney transplantation alone, the combinations of kidney-liver (aHR, 1.94; 95% CI, 1.77-2.12), kidney-heart (aHR, 2.35; 95% CI, 1.96-2.83), and kidney-lung (aHR, 6.03; 95% CI, 3.39-10.70) transplantation were associated with increased mortality. Many combinations of MOT are associated with increased mortality and graft failure rates. As MOT increases, a sensible allocation policy is needed for patients with multiorgan failure to ensure equitable distribution of these scarce resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.